Prognostic Significance of Procalcitonin in Acute Ischemic Stroke Patients in India
Corresponding Author(s) : S.J. Sanketh
jayanna2013@gmail.com
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 11 No. 1 (2023): 2023 Volume -11 - Issue 1
Abstract
Introduction: Ischemic stroke is one of leading cause of mortality and it is serious long term disability worldwide. Ischemic stroke is the most common type of stroke, and it develops due to a blockage in the arteries around the brain. PCT was not commonly used as a diagnostic marker in India for acute ischemic stroke.
Keywords
Acute Ischemic Stroke, Procalcitonin, Diagnostic Marker, India
1.
Shashidhar Khanapure, S.J. Sanketh, Shreeram A. Kora. Prognostic Significance of Procalcitonin in Acute Ischemic Stroke Patients in India. Int. J. of Allied Med. Sci. and Clin. Res. [Internet]. 2023 Feb. 3 [cited 2026 Apr. 13];11(1):23-6. Available from: https://ijamscr.com/ijamscr/article/view/1281
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
References
-
References:
1. Zhang ZG, Wang C, Wang J, et al. Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. MolNeurobiol. 2015;51:230-239
2. Murad LB, Guimaraes MR, Paganelli A, de Oliveira CA and Vianna LM. Alpha-tocopherol in the brain tissue preservation of stroke-prone spontaneously hypertensive rats. J PhysiolBiochem 2014; 70: 49-60.
3. Tu WJ, Zhao SJ, Liu TG, et al. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurol Res 2013;35(9):912–21.
4. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57–62.
5. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, C. Bohuon, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet 341 (8844) (1993) 515–518.
6. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24(2):185-188.
7. Li YM and Liu XY. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke. J Neurol Sci 2015; 352: 68-73.
8. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541-53.
9. Feigin VL. Stroke epidemiology in the developing world. Lancet. 2005 Jun 25-Jul 1;365(9478):2160-1.
10. Yan L, Wang S, Xu L, Zhang Z, Liao P. Procalcitonin as a prognostic marker of patients with acute ischemic stroke. J Clin Lab Anal. 2020 Jul;34(7):e23301.
11. Li G, Zhu C, Li J, Wang X, Zhang Q, Zheng H, Zhan C. Increased level of procalcitonin is associated with total MRI burden of cerebral small vessel disease in patients with ischemic stroke. NeurosciLett. 2018 Jan 1;662:242-246.
12. Tian D, Zhang S, He X, Liu H. Serum procalcitonin as a diagnostic marker in acute ischemic stroke. Neuroreport. 2015 Jan 7;26(1):33-7.
References
References:
1. Zhang ZG, Wang C, Wang J, et al. Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. MolNeurobiol. 2015;51:230-239
2. Murad LB, Guimaraes MR, Paganelli A, de Oliveira CA and Vianna LM. Alpha-tocopherol in the brain tissue preservation of stroke-prone spontaneously hypertensive rats. J PhysiolBiochem 2014; 70: 49-60.
3. Tu WJ, Zhao SJ, Liu TG, et al. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurol Res 2013;35(9):912–21.
4. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57–62.
5. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, C. Bohuon, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet 341 (8844) (1993) 515–518.
6. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24(2):185-188.
7. Li YM and Liu XY. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke. J Neurol Sci 2015; 352: 68-73.
8. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541-53.
9. Feigin VL. Stroke epidemiology in the developing world. Lancet. 2005 Jun 25-Jul 1;365(9478):2160-1.
10. Yan L, Wang S, Xu L, Zhang Z, Liao P. Procalcitonin as a prognostic marker of patients with acute ischemic stroke. J Clin Lab Anal. 2020 Jul;34(7):e23301.
11. Li G, Zhu C, Li J, Wang X, Zhang Q, Zheng H, Zhan C. Increased level of procalcitonin is associated with total MRI burden of cerebral small vessel disease in patients with ischemic stroke. NeurosciLett. 2018 Jan 1;662:242-246.
12. Tian D, Zhang S, He X, Liu H. Serum procalcitonin as a diagnostic marker in acute ischemic stroke. Neuroreport. 2015 Jan 7;26(1):33-7.
1. Zhang ZG, Wang C, Wang J, et al. Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. MolNeurobiol. 2015;51:230-239
2. Murad LB, Guimaraes MR, Paganelli A, de Oliveira CA and Vianna LM. Alpha-tocopherol in the brain tissue preservation of stroke-prone spontaneously hypertensive rats. J PhysiolBiochem 2014; 70: 49-60.
3. Tu WJ, Zhao SJ, Liu TG, et al. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurol Res 2013;35(9):912–21.
4. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57–62.
5. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, C. Bohuon, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet 341 (8844) (1993) 515–518.
6. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24(2):185-188.
7. Li YM and Liu XY. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke. J Neurol Sci 2015; 352: 68-73.
8. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541-53.
9. Feigin VL. Stroke epidemiology in the developing world. Lancet. 2005 Jun 25-Jul 1;365(9478):2160-1.
10. Yan L, Wang S, Xu L, Zhang Z, Liao P. Procalcitonin as a prognostic marker of patients with acute ischemic stroke. J Clin Lab Anal. 2020 Jul;34(7):e23301.
11. Li G, Zhu C, Li J, Wang X, Zhang Q, Zheng H, Zhan C. Increased level of procalcitonin is associated with total MRI burden of cerebral small vessel disease in patients with ischemic stroke. NeurosciLett. 2018 Jan 1;662:242-246.
12. Tian D, Zhang S, He X, Liu H. Serum procalcitonin as a diagnostic marker in acute ischemic stroke. Neuroreport. 2015 Jan 7;26(1):33-7.